SUPPLIER PROFILE

Chunghwa Chemical Synthesis & Biotech

Chunghwa Chemical Synthesis & Biotech is a Pharmaceutical company, CMO/CDMO company operating in the pharmaceutical industry.

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB), founded in 1964, is one of the largest API manufacturers in Taiwan. CCSB is a FDA /EU approved cGMP API plant to produce synthesis and biotechnology products. CCSB has filed US DMF, EDMF and COS for several products. Our products include Mycophenolate Mofetil, Rapamycin (Sirolimus), Tacrolimus Monohydrate, Everolimus, Caspofungin Acetate , etc. CCSB also offers contract manufacturing in the cGMP plants.

Company type

Pharmaceutical company, CMO/CDMO

Products and services

APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services

Geographies they support

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address


Chunghwa Chemical Synthesis & Biotech, 1 Tung-Hsing Street, Shu-Lin Dist., New Taipei City, , Taiwan, China, 23850

Do you work for Chunghwa Chemical Synthesis & Biotech? Claim your profile here
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.